Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2016 / Honorees / Frank Holz

Frank Holz

  • Profile

About Frank Holz

Frank Holz

Chairman and Professor, Department of Ophthalmology, University of Bonn

Frank Holz is a researcher whose many interests include the pathogenesis, prognostic factors, biomarkers and therapy of AMD, phenotyping retinal diseases using innovative imaging technologies, the development and implementation of molecular imaging for macular and retinal diseases, and understanding the cell biology of retinal pigment epithelial cells in atrophic and neovascular ocular diseases. He has also been involved in several high profile clinical trials involving innovative therapies for macular disease. Holz has made significant advances in the understanding of macular telangiectasia, including characterizing the natural history in many patients and identifying early markers of the disease, along with better imaging methods for following disease progression. For the last three decades, he has been at the forefront of clinical research using the most advanced retinal imaging modalities, and is one of the early adopters of OCT-angiography (and one of the world’s leading authorities on its use). He is Editor-in-Chief of the journal of the German Ophthalmological Society (DOG), Der Ophthalmologe, and a past president of DOG. 

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: